Atossa Therapeutics Filed A Petition For Post Grant Review With The U.S. Patent And Trademark Office Relating To One Of The Company's Issued Patents Related To Methods For Making And Using Endoxifen
Portfolio Pulse from Benzinga Newsdesk
Atossa Therapeutics has filed a petition for post grant review with the U.S. Patent and Trademark Office relating to one of the company's issued patents related to methods for making and using Endoxifen.
August 31, 2023 | 10:56 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Atossa Therapeutics' petition for post grant review could potentially impact the validity of one of its patents related to Endoxifen.
The filing of a post grant review by Atossa Therapeutics could potentially impact the validity of one of its patents. This could have implications for the company's intellectual property rights and potentially its revenue streams if the patent is found to be invalid. However, the outcome of the review is uncertain at this stage, hence the neutral score.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100